Home > Boards > US Listed > Telecommunications Hardware > ADC Telecommunications (ADCT)

Morning Tom, Here is some news on patent win.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
LemonHead Member Profile
Member Level 
Followed By 8
Posts 693
Boards Moderated 0
Alias Born 01/31/02
160x600 placeholder
ADC Therapeutics organisera une conférence téléphonique consacrée à ses résultats financiers du troisième trimestre le 2 novembre 2021 Business Wire - 10/27/2021 11:30:00 AM
ADC Therapeutics setzt eine Telefonkonferenz zur Besprechung der Finanzergebnisse des dritten Quartals 2021 für den 2. November 2021 an Business Wire - 10/27/2021 9:12:00 AM
ADC Therapeutics to Host Third Quarter 2021 Financial Results Conference Call on November 2, 2021 Business Wire - 10/27/2021 7:15:00 AM
Overland ADCT BioPharma gibt erste Verabreichung an Patienten in China von ZYNLONTA® im Rahmen klinischer Phase-II-Zulassungsstudie zu diffus großzelligem B-Zell-Lymphom bekannt Business Wire - 9/29/2021 5:18:00 PM
Overland ADCT BioPharma annonce la première administration à un patient de ZYNLONTA® dans le cadre d'un essai clinique pivot de Phase 2 conduit en Chine pour le traitement du lymphome diffus à grandes cellules B Business Wire - 9/29/2021 5:16:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/29/2021 7:23:25 AM
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA® in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma Business Wire - 9/29/2021 7:15:00 AM
ADC Therapeutics verabreicht in klinischer Phase-1-Studie zu ADCT-901 bei fortgeschrittenen soliden Tumoren die erste Dosis an einen Patienten Business Wire - 9/27/2021 12:46:00 PM
ADC Therapeutics dose un premier patient dans le cadre d'un essai clinique de Phase 1 avec ADCT-901 pour traiter les tumeurs solides avancées Business Wire - 9/27/2021 9:35:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/27/2021 7:18:44 AM
ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors Business Wire - 9/27/2021 7:15:00 AM
ADC Therapeutics nimmt an der Cantor Virtual Global Healthcare Conference 2021 teil Business Wire - 9/23/2021 4:39:00 PM
ADC Therapeutics participera à l’édition 2021 de la Cantor Virtual Global Healthcare Conference Business Wire - 9/23/2021 8:44:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/23/2021 7:23:29 AM
ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference Business Wire - 9/23/2021 7:15:00 AM
ADC Therapeutics erhält Orphan-Drug-Status in Europa für ZYNLONTA® Business Wire - 9/13/2021 9:36:00 PM
ADC Therapeutics a reçu la désignation de médicament orphelin en Europe pour ZYNLONTA® Business Wire - 9/13/2021 8:36:00 AM
ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA® Business Wire - 9/13/2021 7:15:00 AM
ADC Therapeutics participera à la 19e conférence annuelle mondiale sur les soins de santé de Morgan Stanley Business Wire - 9/9/2021 1:55:00 PM
ADC Therapeutics nimmt an der 19. jährlichen globalen Gesundheitskonferenz von Morgan Stanley teil Business Wire - 9/9/2021 8:47:00 AM
ADC Therapeutics to Participate in Morgan Stanley’s 19th Annual Global Healthcare Conference Business Wire - 9/9/2021 7:15:00 AM
ADC Therapeutics gibt Wechsel in der medizinischen Führungsspitze bekannt Business Wire - 9/3/2021 3:12:00 PM
ADC Therapeutics annonce une transition au niveau de sa direction médicale Business Wire - 9/3/2021 9:38:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/3/2021 7:22:53 AM
ADC Therapeutics Announces Medical Leadership Transition Business Wire - 9/3/2021 7:15:00 AM
LemonHead Member Level  Wednesday, 10/30/02 10:36:42 AM
Re: OldAIMGuy post# 10
Post # of 46 
Morning Tom, Here is some news on patent win.


BW2048 OCT 30,2002 4:03 PACIFIC 07:03 EASTERN

( BW)(MN-ADC)(ADCT) ADC Wins RF Circuit Module Patent Infringement Suit

Business Editors & High-Tech Writers

MINNEAPOLIS--(BUSINESS WIRE)--Oct. 30, 2002--ADC (Nasdaq:ADCT; www.adc.com) today announced that it has resolved a patent infringement action against PCI Technologies, a suit ADC filed in 2001 to enforce a patent relating to ADC's radio frequency (RF) modules used in its RFWorx(R) platform. Under the resolution, ADC will receive a monetary payment and PCI must discontinue its MAXNET line of RF modules, as they existed at the time ADC filed suit. PCI will redesign the product to conform with agreed upon specifications. ADC has reserved the right to pursue PCI for infringement of any other ADC patents, including any future ADC patents that could provide additional protection for ADC's RF modules.
The RFWorx platform is designed to help multiple service operators (MSOs) deliver traditional video and future targeted services over the same network by balancing headend signals with minimal service interruptions.
"This is an excellent outcome for ADC," said Rick Roscitt, chairman and CEO for ADC. "A great deal of research and development dollars are spent each year to innovate new products for cable, wireline and wireless carriers. This suit sends a clear message to our competition, customers, and shareholders that the cable network business is very important to ADC's future, and that ADC will protect its research and development dollars by enforcing its patents."
"RFWorx and other ADC products help cable providers build the best carrier-class networks available today," said Rob Cain, director of broadband products for ADC. "We'll continue to innovate new technical advances and enhance existing products for our service provider customers."
ADC was represented by its patent litigation counsel, Alan G. Carlson, Philip P. Caspers, Timothy A. Lindquist, and Anthony R. Zeuli of Merchant & Gould, Minneapolis.

About ADC

ADC is The Broadband Company(TM). ADC offers high-quality, value-added solutions of network equipment, software and systems integration services that enable communications service providers to deliver high-speed Internet, data, video and voice services to consumers and businesses worldwide. ADC (Nasdaq:ADCT) has sales into nearly 100 countries and is included in the Standard & Poor's 500 Index and the NASDAQ 100 Index. Learn more about ADC Telecommunications, Inc. at www.adc.com.


CONTACT: ADC, Minneapolis
Public Relations:
Chuck Grothaus, 952/917-0306
Investor Relations:
Mark Borman, 952/917-0590

SOURCE: ADC Telecommunications, Inc.

PS - Great post on the AIM board this am. I saved it...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences